UM

Browse/Search Results:  1-10 of 20 Help

Selected(0)Clear Items/Page:    Sort:
Recent advances in bioaffinity strategies for preclinical and clinical drug discovery: Screening natural products, small molecules and antibodies Journal article
Jin, Haochun, Cui, Dianxin, Fan, Yu, Li, Guodong, Zhong, Zhangfeng, Wang, Yitao. Recent advances in bioaffinity strategies for preclinical and clinical drug discovery: Screening natural products, small molecules and antibodies[J]. Drug Discovery Today, 2024, 29(3), 103885.
Authors:  Jin, Haochun;  Cui, Dianxin;  Fan, Yu;  Li, Guodong;  Zhong, Zhangfeng; et al.
Favorite | TC[WOS]:4 TC[Scopus]:6  IF:6.5/7.3 | Submit date:2024/04/02
Antibodies  Bioaffinity Strategy  Drug Discovery  Natural Products  Small Molecule  
Corrigendum: Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao (Frontiers in Immunology, (2023), 14, (1131985), 10.3389/fimmu.2023.1131985) Other
2024-01-01
Authors:  Ng, Hoi Man;  Lei, Chon Lok;  Fu, Siyi;  Li, Enqin;  Leong, Sek In; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0 | Submit date:2024/05/16
Antibodies  Heterologous Vaccinations  Inactivated Vaccine  Macao  Mrna Vaccine  Nucleocapsid Proteins  Sars-cov-2  Spike Proteins  
A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov Journal article
Yang, Jing, Kang, Heming, Lyu, Liyang, Xiong, Wei, Hu, Yuanjia. A target map of clinical combination therapies in oncology: an analysis of clinicaltrials.gov[J]. Discover Oncology, 2023, 14(1), 151.
Authors:  Yang, Jing;  Kang, Heming;  Lyu, Liyang;  Xiong, Wei;  Hu, Yuanjia
Favorite | TC[WOS]:7 TC[Scopus]:7 | Submit date:2023/09/21
Bispecific Antibodies  Combination Therapy  Immuno-oncology Therapy  Kinase Inhibitors  Pd-1/pd-l1 Inhibitors  Targeted Therapy  
Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao Journal article
Ng,Hoi Man, Lei,Chon Lok, Fu,Siyi, Li,Enqin, Leong,Sek In, Nip,Chu Iong, Choi,Nga Man, Lai,Kai Seng, Tang,Xi Jun, Lei,Chon Leng, Xu,Ren He. Heterologous vaccination with inactivated vaccine and mRNA vaccine augments antibodies against both spike and nucleocapsid proteins of SARS-CoV-2: a local study in Macao[J]. Frontiers in Immunology, 2023, 14.
Authors:  Ng,Hoi Man;  Lei,Chon Lok;  Fu,Siyi;  Li,Enqin;  Leong,Sek In; et al.
Favorite | TC[WOS]:3 TC[Scopus]:2  IF:5.7/6.8 | Submit date:2023/08/03
Antibodies  Heterologous Vaccinations  Inactivated Vaccine  Macao  Mrna Vaccine  Nucleocapsid Proteins  Sars-cov-2  Spike Proteins  
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Journal article
Ye,Zi Han, Yu,Wei Bang, Huang,Mu Yang, Chen,Jun, Lu,Jin Jian. Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives[J]. Acta Pharmaceutica Sinica B, 2023, 13(4), 1467-1487.
Authors:  Ye,Zi Han;  Yu,Wei Bang;  Huang,Mu Yang;  Chen,Jun;  Lu,Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date:2023/08/03
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Review article
2023
Authors:  Ye, Zi Han;  Yu, Wei Bang;  Huang, Mu Yang;  Chen, Jun;  Lu, Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date:2023/05/02
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants Journal article
Liao, Guochao, Lau, Hungyan, Liu, Zhongqiu, Li, Chinyu, Xu, Zeping, Qi, Xiaoxiao, Zhang, Yu, Feng, Qian, Li, Runze, Deng, Xinyu, Li, Yebo, Zhu, Qing, Zhu, Sisi, Zhou, Hua, Pan, Hudan, Fan, Xingxing, Li, Yongchao, Li, Dan, Chen, Liqing, Ke, Bixia, Cong, Zhe, Lv, Qi, Liu, Jiangning, Liang, Dan, Li, An’an, Hong, Wenshan, Bao, Linlin, Zhou, Feng, Gao, Hongbin, Liang, Shi, Huang, Bihong, Wu, Miaoli, Qin, Chuan, Ke, Changwen, Liu, Liang. Single-dose rAAV5-based vaccine provides long-term protective immunity against SARS-CoV-2 and its variants[J]. Virology Journal, 2022, 19(1).
Authors:  Liao, Guochao;  Lau, Hungyan;  Liu, Zhongqiu;  Li, Chinyu;  Xu, Zeping; et al.
Favorite | TC[WOS]:5 TC[Scopus]:5  IF:4.0/3.8 | Submit date:2023/01/30
Neutralizing Antibodies  Raav5  Sars-cov-2  Vaccine  Virus Challenge  
Quantitation and Identification of Therapeutic Anti-CD22 Monoclonal Antibodies in a Cell-Based ELISA Method Journal article
Fu, Shengyu, Zhao, Qi. Quantitation and Identification of Therapeutic Anti-CD22 Monoclonal Antibodies in a Cell-Based ELISA Method[J]. Antibodies, 2022, 11(3), 53.
Authors:  Fu, Shengyu;  Zhao, Qi
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.0/4.7 | Submit date:2022/08/27
Cd22  Elisa  Monoclonal Antibodies  
Anti-fouling poly adenine coating combined with highly specific CD20 epitope mimetic peptide for rituximab detection in clinical patients’ plasma Journal article
Huang,Shengfeng, Tang,Rentao, Zhang,Tingting, Zhao,Jing, Jiang,Zhengjin, Wang,Qiqin. Anti-fouling poly adenine coating combined with highly specific CD20 epitope mimetic peptide for rituximab detection in clinical patients’ plasma[J]. Biosensors and Bioelectronics, 2021, 171(112678).
Authors:  Huang,Shengfeng;  Tang,Rentao;  Zhang,Tingting;  Zhao,Jing;  Jiang,Zhengjin; et al.
Favorite | TC[WOS]:24 TC[Scopus]:25  IF:10.7/9.9 | Submit date:2021/03/02
Anti-fouling Coating  Poly Adenine  Epitope Mimetic Peptide  Rituximab  Therapeutic Monoclonal Antibodies  
Collaboration networks for R&D of monoclonal antibodies: An analysis based on pipeline projects Book chapter
出自: Innovation Value Chain of Chinese Pharmaceuticals, Whitestone, New York:United States-China Intellectual Property Institute Inc., 2017, 页码:135-158
Authors:  Tianhong Yin;  Xiangjun Kong;  Yitao Wang;  Xin Chen;  Yuanjia Hu; et al.
Favorite |  | Submit date:2019/01/14
Monoclonal Antibodies  Research And Development  Network Analysis  Institutional Collaboration Network  Country-based Collaboration Network